Update in postmenopausal osteoporosis management

Why we should use tools to evaluate osteoporosis risk? Olivier Bruyère (ULG) Role of biochemical assessments in the management of osteoporosis. Etienne Cavalier (ULiège) Slides Belgian Menopause society avril 2022 Bisphosphonates vs. denosumab: Advantages and risks. Charlotte Verroken (UGent) Bisphosphonates vs. denosumab MHT and SERMS for osteoporosis: do they still have a place? Serge Rozenberg […]